Keyphrases
Colposcopy
83%
Cervical Cancer
72%
AIDS/HIV
66%
High-risk Human Papillomavirus (HR-HPV)
49%
Cervical Cancer Screening
46%
Cervical Intraepithelial Neoplasia
44%
HIV Status
36%
Cervical Cancer Prevention
32%
Confidence Interval
30%
People Living with HIV (PLHIV)
28%
Human Papillomavirus Testing
27%
Gynecologic Oncology
23%
Women's Interagency HIV Study
21%
American Society
21%
Atypical Squamous Cells of Undetermined Significance (ASC-US)
20%
Consensus Guidelines
20%
HPV16
19%
Papillomavirus Infections
19%
HIV Patients
18%
Pap Test
18%
Cervical Pathology
17%
Cervical Cytology
17%
High-grade Squamous Intraepithelial Lesion
16%
Odds Ratio
16%
Endometrial Cancer
16%
HIV Infection
16%
Oncology Patients
15%
Natural History
15%
Abnormal Cytology
14%
Papanicolaou Smear
14%
Human Papillomavirus Types
13%
Invasive Cervical Cancer
13%
Oncogenic Human Papillomavirus
12%
Overall Survival
12%
Hysterectomy
12%
US Women
11%
Cervical Cancer Patients
11%
CD4 Count
11%
Histology
11%
Squamous Intraepithelial Lesion
11%
Cervical Cancer Knowledge
11%
Risk Factors
10%
United States
10%
Papanicolaou Test
10%
Triage
10%
Human Papillomavirus Vaccine
10%
Multivariate Analysis
10%
Highly Active Antiretroviral Therapy (HAART)
9%
Interferon-α (IFN-α)
9%
Wound Complications
9%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Colposcopy
88%
Wart Virus
69%
Cervical Cancer
65%
Cytotechnology
54%
Malignant Neoplasm
47%
Cervical Intraepithelial Neoplasia
46%
Papanicolaou Stain
42%
Cervical Cancer Screening
41%
Disease
34%
Biopsy Technique
30%
Gynecological Oncology
26%
Uterine Cervix Cytology
19%
Precancerous Condition
19%
Cervical Cancer Prevention
19%
Uterine Cancer
18%
Squamous Cell
18%
Odds Ratio
16%
Patient Referral
15%
Prevalence
15%
Neoplasm
13%
Ovarian Cancer
12%
Overall Survival
12%
Recurrent Disease
12%
Screening Test
11%
Radiation Therapy
11%
Triage
10%
Precursor
10%
Chemotherapy
10%
Human Papillomavirus Type 16
9%
Wound Complication
9%
Cancer
9%
Adolescence
9%
Oncologist
9%
Hysterectomy
8%
Human Immunodeficiency Virus Infection
8%
Multivariate Analysis
8%
Curettage
8%
Adenocarcinoma in Situ
8%
Pelvis
7%
Dysplasia
7%
Papillomavirus Infection
7%
Hazard Ratio
7%
Body Mass Index
7%
Chemoradiotherapy
7%
Metastatic Carcinoma
7%
Cervix
7%
Female Genital Tract Cancer
7%
Uterine Cervix Dysplasia
6%
Progression Free Survival
6%